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Abstract 
Background 
Weak hand grip strength in later life is a risk factor for disability, morbidity and mortality and 
is central to definitions of sarcopenia and frailty. It is unclear whether rate of change in grip 
strength adds to level of grip strength as a risk factor for poor ageing outcomes. 
Methods 
Study participants were 292 community-dwelling men and women whose grip strength was 
measured during the 1994/5 (average age 67) and 2003/5 (average age 76) phases of the 
Hertfordshire Ageing Study, UK. Individual rate of change in grip strength was estimated 
using a residual change method. Mortality was followed-up to 2011 (42 men and 21 women 
died). 
Results  
Average grip strengths in 2003/5 were 38.4kg (standard deviation [SD] 8.1) and 23.7kg (SD 
6.6) for men and women respectively. Average annualised rates of change in grip strength 
(2003/5 minus 1994/5) were modest owing to a healthy-participant effect (men: -0.12kg/year 
SD 0.71; women: 0.08kg/year SD 0.54) but varied widely. Mortality risk varied according to 
level and rate of change in grip strength (p=0.03); death rates per 100 person years of 
follow-up were 6.7 (95%CI 4.6,9.6) among participants who lost grip over time and had low 
grip in 2003/5, in contrast with 0.8 (95%CI 0.1,5.8) among participants whose grip changed 
little over time and remained high in 2003/5. 
Conclusions 
Levels of grip strength in later life should be considered in conjunction with estimates of 
change in grip strength identified by repeat measurement over time. Normative data for 
longitudinal change in grip strength are required. 
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Key points  
 It is unclear whether an individual’s rate of change in hand grip strength acts as a risk 
factor for poor ageing outcomes, over and above their level of grip strength in later life. 
 Using data from the HAS we have identified elevated mortality risks among older 
people who experience accelerated loss of grip strength in later life, especially when in 
combination with a low level of grip strength.  
 Our results have implications for understanding of the utility of grip strength 
measurements made in research and clinical settings and suggest that levels of grip 
strength in later life should be considered in conjunction with estimates of change in grip 
strength identified by repeat measurement over time. 
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Introduction 
Weak hand grip strength in later life is an established risk factor for subsequent disability [1], 
morbidity [2] and mortality [3], Grip strength is central to current definitions of sarcopenia 
[4,5] and physical frailty [6] and there is considerable interest in its role as a marker of 
healthy ageing [7], as an outcome in intervention studies[8], and as a potential tool for 
clinical assessment [9].  
 
Cross-sectional and longitudinal studies have described the lifecourse trajectory of grip 
strength: a period of increase from childhood to a peak in early adult life is apparent, 
followed by maintenance through to midlife, and finally decline from midlife onwards [10,11].   
It is unclear whether an individual’s rate of change in grip strength acts as a risk factor for 
poor ageing outcomes, over and above their level of grip strength in later life. 
 
We are aware of only seven published studies which have taken longitudinal measurements 
of grip strength in later life and related rate of change in grip strength to subsequent risk of 
mortality [12-18]. These studies differed in many ways: three were based in the United 
States (the RUSH [12], Baltimore Longitudinal Study of Ageing [15], and Women’s Health 
and Ageing Study [18]), the others in Canada (Canadian Health Survey [13]), the 
Netherlands (Leiden 85+ Study [14]), Denmark (1905 Birth Cohort [16]) and Sweden (a 
study of twins [17]); sample sizes ranged from a few hundred to several thousand study 
participants; five of the studies considered men and women [12-14,16,17], one studied only 
men[15], and one only women[18]; the average baseline age of the study participants was 
typically late-seventies to early-eighties but ranged from mid-sixties to mid-nineties; 
longitudinal measurement of grip strength was conducted across periods of time ranging 
from two to twenty-five years, with a median number of four grip strength measurements per 
study (range: 2 to 12); and mortality follow-up ranged from two to forty years. The studies 
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also differed in their conclusions about the relative importance of level and rate of change in 
grip strength in later life as risk factors for subsequent mortality: three studies concluded that 
level of grip strength is a more important risk factor for mortality than rate of change in grip 
strength [12,15,16]; two studies concluded that accelerated loss of grip strength is a stronger 
risk factor for mortality than level of grip strength [13,17]; and two studies concluded that 
level and rate of change in grip strength are both risk factors for mortality [14,18]. No UK 
studies to date have explored the association between level and rate of change in grip 
strength in later life as risk factors for mortality. 
 
We have addressed this gap in knowledge by exploring the association between level, and 
rate of change, of grip strength in later life and risk of mortality among the 292 community-
dwelling men and women who participated in the 1994/5 and 2003/5 phases of the 
Hertfordshire Ageing Study, UK, and for whom mortality was followed-up to 2011. 
 
Methods 
The Hertfordshire Ageing Study (HAS) has been described previously [19]. A full account of 
the methods pertinent to this paper may be found in Appendix 1 on the journal’s website. In 
brief, 292 men and women, born 1920-1930, attended research clinics in Hertfordshire in 
1994/5 and 2003/5 and had grip strength measured at both waves of follow-up. All-cause 
mortality was ascertained for all participants till 13/01/2011.  
 
A research nurse measured grip strength at each clinic using a standard protocol [20]; 
Harpenden and Jamar dynamometers were used in 1994/5 and 2003/5 respectively.  Intra- 
and inter-observer studies were carried out during the fieldwork (see Appendix 1 for details). 
The HAS had ethical approval from the Hertfordshire and Bedfordshire Local Research 
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Ethics Committee and all participants gave written informed consent. This work was 
supported by the Medical Research Council (MC_UP_A620_1015, MC_UU_12011/2).  
Statistical methods 
Maximum grip strength values were calculated from all available measurements at the 
1994/5 clinic and similarly at the 2003/5 clinic.   
Characterisation of change in a clinical phenotype is challenging when data are only 
available at two time points and the phenotype may be subject to the effects of regression to 
the mean; in this instance, simple calculation of absolute or percentage change may poorly 
reflect magnitude of change and will be artefactually negatively associated with initial value 
[21]. To overcome these problems, we characterised change in grip strength by estimating 
sex-specific linear regression models for grip strength in 2003/5 on grip strength in 1994/5 
with adjustment for individual follow-up duration; the standardised residuals from these 
models function as Twisk’s recommended measure of “residual change” [21] in grip strength 
over time. For illustrative purposes only, thirds of the distribution of residual change were 
regarded as providing evidence of “loss”, “no change”, or “gain” of grip strength.  
Cox’s proportional hazards models were used to analyse associations between “residual 
change” in grip strength between HAS clinics, and levels of grip strength in 1994/5 and 
2003/5, and risk of mortality between the 2003/5 clinic and 13/01/2011. We considered 
independent, interaction, and quadratic (second order) effects of grip strength on mortality 
risk. To maximise sample size, analyses were principally conducted for men and women 
combined with adjustment for gender. Analyses were conducted using Stata, release 11.   
 
Results 
Participant characteristics are shown in table 1; 42 men and 21 women died prior to 
13/01/2011. Consistent with a healthy survivor effect in HAS [19] a modest average decline 
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in grip strength was observed between clinics among men (p=0.03) but not women (p=0.13). 
Nonetheless, substantial variation in annualised change in grip strength was evident for both 
men (median and [5th, 25th, 75th, 95th centiles]: -0.05kg/year [-1.34,-0.56, 0.46,0.93]) and 
women (0.08kg/year [-0.80,-0.35,0.43,0.91]) and older age at baseline clinic was associated 
with accelerated loss of grip strength among men and women. In addition, men who were 
shorter, had higher BMI and reported slower walking speed at baseline, experienced 
accelerated loss of grip strength (data not shown). 
 
Older age, shorter stature and slower walking speed in 2003/5 were associated with lower 
concurrent grip strength among men and women, and women with many systems medicated 
had lower grip strength.  Older age, slower walking speed and having more systems 
medicated at the 2003/5 clinic were associated with increased risk of mortality to 13/01/2011 
among men and women. Lower social class was associated with increased mortality among 
men only. These characteristics were regarded as potential confounders of the relationships 
between level and loss of grip strength and mortality in subsequent analyses. 
 
Figure 1 shows that mortality risk between 2003/5 follow-up and 13/01/2011 varied 
according to combinations of loss of grip strength between HAS follow-ups, and level of grip 
strength at 2003/5 clinic..  Loss of grip strength was associated with increased mortality but 
this was accentuated among participants with lower grip strengths in 2003/5 ; conversely, 
low grip strength in 2003/5 was associated with increased mortality risk but this was 
accentuated among individuals who experienced the greatest loss of grip strength between 
follow-ups. For example, the death rate per 100 person years of follow-up (pyrs) was 6.7 
(95%CI 4.6,9.6) among individuals who lost grip strength between clinics and had a grip 
strength in the lowest third of the distribution in 2003/5; in contrast, the death rate was 0.8 
(95%CI 0.1,5.8) per 100 pyrs among individuals who experienced no change in grip strength 
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and maintained strength in the highest third of the distribution in 2003/5. Evidence for 
interaction between loss and level of grip strength as predictors of mortality was significant at 
the 5% level without and with adjustment for potential confounders (see footnote to figure 1) 
and the pattern of interaction was consistent for men and women (p=0.61 for a null 
hypothesis that supports a homogenous pattern of interaction between men and women).   
 
Figure 2 presents contour plots for combinations of measurements of grip strength in 1994/5 
and 2003/5 which are estimated to have the same relative risk for mortality in comparison 
with a reference risk of 1 for individuals with average grip strength at both clinics. The 
contour patterns in Figure 2 confirm that changes in grip strength combine with levels of grip 
strength to influence mortality risk; overall, lower grip strength in 2003/5 was associated with 
increased mortality risk among men and women (note elevated risk contours in the bottom 
half of the plots) but risks were particularly accentuated if low strength in 2003/5 followed on 
from a higher level in 1994/5 (note particularly elevated risk contours in the bottom right 
quadrants of the plots).  
 
Discussion 
Using data from the HAS we have identified elevated mortality risks among older people who 
experience accelerated loss of grip strength in later life, especially when in combination with 
a low level of grip strength. These results have implications for understanding of the utility of 
grip strength measurements made in research and clinical settings. Our results suggest that 
levels of grip strength at any given point in later life should be considered in conjunction with 
estimates of change in grip strength from repeat measurement over time. 
 
Our conclusion that change combines with level of grip strength as a predictor of mortality in 
later life is consistent with findings by Ling [14] and Xue [18] who studied older people 
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participating in the Leiden 85-plus and the Women’s Health and Aging Study II respectively. 
In contrast, Buchman [12], Hirsch [13], Metter [15], Oksuzyan [16], and Proctor [17] found 
that  level of grip strength was more predictive of mortality risk than change in grip strength, 
and Hirsch [13] and Proctor [17] identified change in grip strength as a stronger predictor of 
mortality than level.  Further studies are required to elucidate the relative importance of level 
and change in grip strength as risk factors for poor ageing outcomes. Future studies would 
be well advised: to include many repeated measurements of grip strength within the same 
individuals over time; to study different phases of later life; and to examine a wide range of 
ageing outcomes such as disability and morbidity in addition to mortality.  
 
If level and rate of change in grip strength in later life are to have utility as outcomes in 
intervention studies, and are to have prognostic value in clinical assessment, normative data 
are required. Dodds et al have recently established lifecourse normative data for grip 
strength by pooling cross-sectional data from twelve British studies [10]; however, these 
normative data are unlikely to be applicable in low to middle-income countries and in 
different ethnic settings [22].  Studies from Sweden [23], Japan [24], the United States 
[11,25], Denmark [26] and Finland [27] have described within-person longitudinal change in 
grip strength in later life but no normative data for longitudinal change in grip strength are 
available for the UK; the development of such norms is an important area for future 
research.  
 
Our study has some limitations. First, a healthy participant effect is, unsurprisingly, evident in 
HAS [19]; this selection effect has the potential to bias our results. However, our analyses 
were internal to the HAS sample; bias would only be introduced if the associations between 
mortality and level and loss of grip strength were systematically different among those who 
participated in our study, and those who did not; this seems unlikely. Second, grip strength 
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measurements were only available at two time points; our change measure may not fully 
reflect underlying individual rate of change in grip strength. However, we were careful to 
implement Twisk’s [21] recommended “residual change” approach  and also conducted 
complementary analyses based on second order models for baseline and follow-up grip 
strength measurements in relation to mortality which avoided direct calculation of change; 
results were consistent which suggests that the results from either one of the approaches 
are not simply due to statistical artefact. Nonetheless, our results require replication and 
extension in datasets including many longitudinal measurements of grip strength. Finally, 
although measured according to identical protocol [20], grip strength was measured using 
different dynamometers in 1994/5 and 2003/5; we acknowledge this as a limitation of our 
study. However, Dodds et al have shown that different dynamometers have minimal impact 
on normative values for grip strength across the lifecourse [10]. Moreover, use of different 
dynamometers  is unlikely to have affected the ranking of grip strength loss for HAS 
participants.  
 
Our study also has many strengths. First, few studies to date have explored the association 
between mortality and longitudinal change in grip strength in later life; we have added to this 
limited literature with the first study of its kind from the UK. Second, we conducted a careful 
analysis of the HAS longitudinal grip strength data which acknowledged the potential impact 
of regression to the mean and the limitation of only two repeat measurements. Finally, all 
measurements in HAS were made according to strict protocol by trained research nurses 
working as part of an experienced multi-disciplinary research team.  
In conclusion, our results have implications for understanding of the utility of grip strength 
measurements made in research and clinical settings and suggest that levels of grip strength 
at any given point in later life should be considered in conjunction with estimates of change 
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in grip strength identified by repeat measurement over time. Normative data for longitudinal 
changes in grip strength in later life are now required.  
Conflicts of interest 
None declared. 
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Table 1. Characteristics of Hertfordshire Ageing Study (HAS) participants 
Mean (SD) Men (n=172) Women (n=120) 
      
1994/5    
Age (yrs) 67.1 (2.3) 67.2 (2.1) 
   
Maximum grip strength (kg) 39.5 (6.0) 23.0 (5.4) 
   
Social class: I-IIINM+ 83 (49%) 50 (42%) 
         
2003/05   
Age (yrs) 76.5 (2.3) 76.2 (2.1) 
   
Follow-up time (yrs)* 9.6 (9.0, 9.8) 9.1 (8.7, 9.4) 
   
Maximum grip strength (kg) 38.4 (8.1) 23.7 (6.6) 
   
Annualised change in grip strength (kg/yr) -0.12 (0.71) 0.08 (0.54) 
   
Height (cm) 171.4 (6.3) 158.2 (5.5) 
   
Weight (kg) 81.3 (13.9) 69.9 (13.7) 
   
Smoking status+: Never 56 (33%) 51 (43%) 
                            Ex 100 (58%) 61 (51%) 
                            Current 16 (9%) 8 (7%) 
   
High weekly alcohol intake+ (≥22M; ≥15F units per week) 16 (9%) 7 (6%) 
   
Walking speed (self-reported)+: Slow/Stroll 75 (44%) 59 (50%) 
                                                  Normal speed 71 (41%) 40 (34%) 
                                                  Brisk/Fast 26 (15%) 20 (17%) 
   
Number of systems medicated* 2.0 (1.0, 3.0) 2.0 (1.0, 3.0) 
   
Fracture since 45 years age+ 19 (11%) 35 (29%) 
   
Stroke/TIA+ 18 (11%) 7 (6%) 
   
Hypertension+ 116 (67%) 71 (59%) 
Deaths between 2003/05 follow-up and 13/01/2011+ 42 (24%) 21 (18%) 
+n(%);  *Median (Lower quartile, Upper quartile);  SD: standard deviation; Yr: year; I-IIINM: classes I to III non-
manual of registrar general’s social class coded to the SOC90 classification of occupations of most recent full-
time occupation and with social class for ever married women assigned the social class of their husband; M: 
males; F: females; TIA: transient ischaemic attack  
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Figure 1. Mortality rates in HAS men and women combined subsequent to 2003/5 
clinic according to level of grip strength at the HAS 2003/5 clinic and change in grip 
strength between 1994/5 and 2003/5 clinics 
 
Footnotes:  
P-value for interaction between level and residual change in grip strength, adjusted for gender: p=0.03. P=0.02 
also adjusted for age, height and weight residual; p=0.01 also adjusted for social class, walking speed, smoking 
habit and alcohol intake; p=0.06 also adjusted for number of systems medicated 
Error bars represent 95% confidence limits. 
Thirds of the grip strength distribution at 2003/5 clinic were identified by:  “lowest” third 15-34kg for men and 2-
22kg for women; “middle” third 35-42kg for men and 23-27kg for women; “highest” third 43-58kg for men and 28-
39kg for women.  
Median crude annualised changes in grip strength (2003/5 minus 1994/5, divided by follow-up duration) within 
each third of the residual change in grip strength distribution were: “loss” -0.72 kg/year among men and -0.44 
kg/year among women; “no change” -0.05kg/year for men and 0.08kg/year for women; “gain” 0.61kg/year among 
men and 0.59kg/year among women.  
Only 2 men and 1 woman experienced loss of grip strength whilst maintaining a grip strength in the highest third 
of the sex-specific distribution at 2003/5 clinic; none of these men and women died. This death rate estimate has 
been regarded as missing and omitted from the figure.  
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Figure 2. Contour plots for combinations of grip strength measurements at HAS 1994/5 and 
2003/5 clinics which were estimated to have the same hazard ratio for mortality in comparison 
with a reference group of individuals with average grip strength at each phase of follow-up.  
 
 
Footnotes:  
These contour plots were derived by fitting a second order model for mortality on linear terms for grip strength at 1994/5 and 
2003/5 clinics, in addition to an interaction term, and quadratic terms for each of these grip strength values. A second order 
model provided a better description of mortality risk than a model that only included linear terms for grip strength at each follow-
up (p<0.05 with or without adjustment for potential confounders).  
Average grip strengths among men were 39.5kg and 38.4kg at HAS 1994/5 and 2003/5 clinics respectively; corresponding 
figures for women were 23.0kg and 23.7kg.  
The diagonal lines reflect identical values of grip strength at 1994/5 and 2003/5 follow-ups; combinations of grip strength 
measurements located to the bottom right of the lines reflect loss of grip strength (lower in 2003/5 than 1994/5) and 
combinations to the top left of the lines reflect gain in grip strength.  
  
1
5
2
0
2
5
3
0
3
5
4
0
4
5
5
0
5
5
2
0
0
3
/5
 g
ri
p
 s
tr
e
n
g
th
 (
k
g
)
15 20 25 30 35 40 45 50 55
1994/5 grip strength (kg)
2.00
1.90
1.80
1.70
1.60
1.50
1.40
1.30
1.20
1.10
1.00
0.90
0.80
0.70
0.60
0.50
0.40
0.30
0.20
0.10
Men
5
1
0
1
5
2
0
2
5
3
0
3
5
4
0
2
0
0
3
/5
 g
ri
p
 s
tr
e
n
g
th
(k
g
)
5 10 15 20 25 30 35 40
1994/5 grip strength (kg)
2.00
1.90
1.80
1.70
1.60
1.50
1.40
1.30
1.20
1.10
1.00
0.90
0.80
0.70
0.60
0.50
0.40
0.30
0.20
0.10
Women
Hazard ratio: 
Hazard ratio: 
15 
 
 
References 
 
1. Vermeulen J, Neyens JC, van Rossum E, Spreeuwenberg MD, de Witte LP. Predicting ADL disability 
in community-dwelling elderly people using physical frailty indicators: a systematic review. 
BMC geriatrics 2011;11:33. 
2. Cooper R, Kuh D, Cooper C, et al. Objective measures of physical capability and subsequent health: 
a systematic review. Age Ageing 2011;40(1):14-23. 
3. Cooper R, Kuh D, Hardy R. Objectively measured physical capability levels and mortality: 
systematic review and meta-analysis. BMJ 2010;341:c4467 doi: 10.1136/bmj.c4467. 
4. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and 
diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age 
Ageing 2010;39(4):412-23. 
5. Sayer AA, Robinson SM, Patel HP, et al. New horizons in the pathogenesis, diagnosis and 
management of sarcopenia. Age Ageing 2013;42(2):145-50. 
6. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. JGerontolA 
BiolSciMedSci 2001;56(3):M146-M56. 
7. Sayer AA, Kirkwood TB. Grip strength and mortality: a biomarker of ageing? Lancet 
2015;386(9990):226-7. 
8. Cooper C, Fielding R, Visser M, et al. Tools in the assessment of sarcopenia. Calcified tissue 
international 2013;93(3):201-10. 
9. Sallinen J, Stenholm S, Rantanen T, et al. Hand-grip strength cut points to screen older persons at 
risk for mobility limitation. J Am Geriatr Soc 2010;58(9):1721-6. 
10. Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: Normative data from 
twelve British studies. PLoS ONE 2014;9(12) 
11. Nahhas RW, Choh AC, Lee M, et al. Bayesian longitudinal plateau model of adult grip strength. 
American journal of human biology : the official journal of the Human Biology Council 
2010;22(5):648-56. 
12. Buchman AS, Wilson RS, Boyle PA, Bienias JL, Bennett DA. Change in motor function and risk of 
mortality in older persons. Journal of the American Geriatrics Society 2007;55(1):11-19. 
13. Hirsch CH, Buzkova P, Robbins JA, Patel KV, Newman AB. Predicting late-life disability and death 
by the rate of decline in physical performance measures. Age and Ageing 2012;41(2):155-61. 
14. Ling CHY, Taekema D, De Craen AJM, et al. Handgrip strength and mortality in the oldest old 
population: The Leiden 85-plus study. Cmaj 2010;182(5):429-35. 
15. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause 
mortality in healthy men. Journals of Gerontology - Series A Biological Sciences and Medical 
Sciences 2002;57(10):B359-B65. 
16. Oksuzyan A, Maier H, McGue M, Vaupel JW, Christensen K. Sex differences in the level and rate 
of change of physical function and grip strength in the Danish 1905-cohort study. Journal of 
aging and health 2010;22(5):589-610. 
17. Proctor DN, Fauth EB, Hoffman L, et al. Longitudinal changes in physical functional performance 
among the oldest old: Insight from a study of Swedish twins. Aging Clinical and Experimental 
Research 2006;18(6):517-30. 
18. Xue QL, Beamer BA, Chaves PHM, Guralnik JM, Fried LP. Heterogeneity in rate of decline in grip, 
hip, and knee strength and the risk of all-cause mortality: The women's health and aging 
study II. Journal of the American Geriatrics Society 2010;58(11):2076-84. 
19. Syddall HE, Simmonds SJ, Martin HJ, et al. Cohort profile: The Hertfordshire Ageing Study (HAS). 
IntJEpidemiol 2010;39(1):36-43. 
20. Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical 
and epidemiological studies: towards a standardised approach. Age Ageing 2011;40(4):423-
29. 
16 
 
21. Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide: Cambridge 
University Press, 2003. 
22. Dodds R, Syddall HE, Cooper R, et al. Global variation in grip strength: a systematic review and 
meta-analysis of normative data. Age and Ageing 2016;45(2):209-16. 
23. Daly RM, Rosengren BE, Alwis G, et al. Gender specific age-related changes in bone density, 
muscle strength and functional performance in the elderly: a-10 year prospective 
population-based study. BMC geriatrics 2013;13:71. 
24. Ishizaki T, Furuna T, Yoshida Y, et al. Declines in physical performance by sex and age among 
nondisabled community-dwelling older Japanese during a 6-year period. Journal of 
epidemiology / Japan Epidemiological Association 2011;21(3):176-83. 
25. Dam T, Lee C, Guo M, Mantell E. Gender differences in lean mass and grip strength trajectory 
among community dwelling adults. Journal of the American Geriatrics Society 2014;62:S91. 
26. Frederiksen H, Hjelmborg J, Mortensen J, et al. Age trajectories of grip strength: cross-sectional 
and longitudinal data among 8,342 Danes aged 46 to 102. Annals of epidemiology 
2006;16(7):554-62. 
27. Stenholm S, Harkanen T, Sainio P, Heliovaara M, Koskinen S. Long-term changes in handgrip 
strength in men and women--accounting the effect of right censoring due to death. The 
journals of gerontology 2012;Series A, Biological sciences and medical sciences. 67(10):1068-
74. 
 
  
17 
 
Supplementary material for journal website 
 
Appendix 1 
Methods 
The Hertfordshire Ageing Study (HAS) has been described in detail previously.[19] In brief, 
home interviews and clinics were conducted in 1994/5 and 2003/5 in order to characterise a 
wide range of markers of ageing for 294 men and women who were born in Hertfordshire, 
UK, between 1920 and 1930, and who still lived in the county in the 1990’s. All-cause 
mortality was ascertained for all participants till 13th January 2011.  
 
At the 1994/5 home interview, a trained research nurse ascertained smoking habit, alcohol 
intake, self-reported walking speed, medications, and current or most recent full-time 
occupation and husband’s occupation for ever-married women. At the 1994/5 clinic, 
measurements included height, weight, and grip strength three times in each hand using a 
Harpenden dynamometer with the participant in a seated position with standardised 
encouragement from a research nurse.[20] At the 2003/5 clinic, 292 participants had grip 
strength re-measured using the same protocol and a Jamar dynamometer.  
 
Intra- and inter-observer variability (IOV) studies were carried out during the fieldwork. These 
were conducted at the initial phase of recruitment and training of the team of research 
nurses responsible for taking measurements in clinic and were repeated whenever new staff 
were recruited. IOV participants were recruited from the pool of HAS participants by personal 
invitation from the senior research nurse. Each IOV was designed to examine consistency of 
measurement between ‘observers’ (i.e. to check there was no evidence of a consistent 
measurement bias for any particular research nurse, and to check that they were all 
measuring with similar precision, relative to all-observer average measurements for each 
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participant in the IOV). Each IOV also examined the repeatability of measurements obtained 
by the same observer for the same participants over two repeats, and checked that these 
measures of repeatability were similar for all research nurses. If marked differences were 
identified between observers then further training was subsequently conducted.  To ease the 
burden on the HAS participants who agreed to take part in our IOV studies, we took a 
pragmatic approach and in the case of grip strength conducted IOVs on the basis of a single 
measurement in each hand rather than triplicates. It was usually also unreasonable to 
expect IOV participants to be measured by all participating research nurses so we used latin 
square, and balanced incomplete block, experimental designs to minimise the number of 
measurements that observers had to complete but whilst implementing a design that 
optimised balance in our assessments of the bias and precision in the measurements 
obtained by the different research nurses. We assessed comparability of measurements 
between and within observers by description of means and standard deviations, medians 
and inter-quartile ranges, calculation of 95% reference ranges (mean ± 1.96 standard 
deviations) and graphical inspection of data recorded in the IOVs; we did not formally test for 
differences between observers because for the relatively small number of study participants 
in each IOV (typically 4 to 6 research nurses measured between 8 and 16 study participants) 
we felt these would be uninformative and prone to returning non-significant p-values anyway.  
 
The HAS had ethical approval from the Hertfordshire and Bedfordshire Local Research 
Ethics Committee and all participants gave written informed consent. 
 
Statistical methods 
Participant characteristics were described using basic summary statistics. Weight and height 
were positively correlated at the 2003/5 clinic (men r=0·52,p<0·001; women 
r=0·24,p=0·009); to avoid multicolinearity problems, a standardised residual of weight 
19 
 
adjusted for height was derived. Maximum grip strength values were calculated from all 
available measurements at the 1994/5 clinic and similarly at the 2003/5 clinic.   
Characterisation of change in a clinical phenotype is challenging when data are only 
available at two time points and the phenotype may be subject to the effects of regression to 
the mean; in this instance, a simple calculation of absolute or percentage change may poorly 
reflect magnitude of change and will be artefactually negatively associated with the initial 
value.[21] To overcome these problems we estimated sex-specific linear regression models 
for grip strength in 2003/5 on grip strength in 1994/5 with adjustment for individual duration 
of follow-up between clinics; the standardised residuals from these models function as 
Twisk’s recommended measure of “residual change”[21] in grip strength over time. For 
illustrative purposes, the “residual change” variable was categorised into thirds of its 
distribution with the categories described thereafter as providing evidence of “loss”, “no 
change”, or “gain” of grip strength.  
 
Cox’s proportional hazards models were used to analyse the associations between both 
“residual change” in grip strength between HAS clinics, and the levels of grip strength at the 
1994/5 and 2003/5 clinics, and mortality between the 2003/5 clinic and 13th January 2011. 
We considered independent main effects, potential interaction effects, and quadratic (second 
order) effects of levels and changes in grip strength on risk of mortality. To maximise sample 
size, analyses were principally conducted for men and women combined with adjustment for 
gender, but were repeated for men and women separately. Analyses were conducted with 
and without adjustment for the potential confounding effects of 2003/5 age, height, weight for 
height, smoking status, alcohol consumption, social class in adulthood, walking speed and 
number of systems medicated as a marker of co-morbidity. All analyses were conducted 
using Stata, release 11.   
